Detailed explanation of the latest official instructions for Trelagliptin

1. Indications:

Trelagliptin (Trelagliptin) is a DPP-4 inhibitor. Its mechanism of action is to inhibit the activity of dipeptidyl peptidase-IV (DPP-4), prolong the half-life of glucagon-like peptide-1 (GLP-1), and thereby increase the concentration of GLP-1. This effect helps enhance postprandial insulin secretion and regulate blood sugar levels. GLP-1, as an incretin hormone, can control blood sugar by promoting insulin secretion and inhibiting gastric emptying after meals. Therefore, trotagliptin is suitable for the treatment of patients with type 2 diabetes, especially those who need to improve glycemic control by increasing insulin secretion.

2. Recommended dosage:

The dosage of trotagliptin varies according to the patient's renal function:

Adult patients: The recommended dose is100 mg taken once weekly on the same day each week.

Patients with moderate renal impairment: The recommended dose is50 mg once weekly, also on the same day each week.

This dosage regimen can effectively help patients maintain a constant level of blood sugar and reduce the risk of diabetes-related complications without frequent medication.

3. How to take:

Oral Administration: Tretagliptin should be taken orally, preferably in combination with diet and exercise to enhance therapeutic effects.

Missed dose recovery: If you miss a dose, you should take the missed dose as soon as possible, but you should not take two doses at once. After taking the supplement, you should continue to follow the regular weekly medication plan.

Overdose: If you accidentally take more than the recommended dose, you should consult your attending physician promptly for appropriate treatment advice.

Take medicines on time: Unless otherwise instructed by the doctor, patients should continue to take medicines on time and avoid stopping medicines at will.

4. Adverse reactions:

The side effects of trotagliptin are usually mild. The most common adverse reactions include:

Nasopharyngitis: Patients may experience respiratory symptoms such as throat discomfort and cough.

Rash and itching: Some patients may experience skin discomfort.

Although these side effects are common, serious adverse events such as death and hypoglycemia are not frequently reported in clinical studies. However, trotagliptin is not impossible to cause other adverse reactions, and patients should pay close attention to the effects and adverse reactions of the drug.

5. Things to note:

Diet and exercise therapy: Patients should strictly follow diet and exercise therapy and maintain a healthy lifestyle while taking trolagliptin to enhance the efficacy of the drug.

Risk of hypoglycemia: Although trotagliptin does not directly cause hypoglycemia, it may increase the risk of hypoglycemia, especially when used in combination with other antidiabetic drugs (such as insulin or sulfonylureas). Patients should pay close attention to symptoms of hypoglycemia, such as dizziness, fatigue, palpitations, etc. Once symptoms of hypoglycemia occur, you should immediately take sufficient sugar, such as candy bars, glucose, or sugary drinks.

Vigilance during use: If the patient is concurrently takingα-glucosidase inhibitors (such as voglibose or acarbose), special attention should be paid to the occurrence of hypoglycemia symptoms and timely supplementation with glucose rather than other types of sugar.

Operating dangerous machinery: While taking trolagliptin, especially in the early stages of treatment, patients should avoid operating machinery that requires a high degree of concentration or engaging in high-risk activities (such as working at heights or driving) to prevent accidents caused by hypoglycemia.

6. Principle of action:

Trelagliptin enhances the effect of the incretin hormone GLP-1 by inhibiting the activity of dipeptidyl peptidase-IV (DPP-4). GLP-1 can help lower blood sugar by stimulating the secretion of insulin from the pancreas after a meal, while trotagliptin works by extending the half-life of GLP-1 in the blood and enhancing its effect in promoting insulin secretion, thereby effectively lowering blood sugar after a meal. This mechanism of action of trolagliptin gives it unique advantages in treating type I diabetes and controlling blood sugar.

Reference materials:https://en.wikipedia.org/wiki/Trelagliptin